At-risk people diagnosed with COVID-19 across the United States and Canada can participate in the testing of a common antidepressant.
Tag: BIG Center
The COVID-19 Trial You Can Do By Mail
Antidepressant May Keep COVID-19 Patients Out of the Hospital
None of 80 outpatients who received fluvoxamine in a clinical trial became seriously ill after 15 days.
Trial Tests OCD Med to Fight COVID-19
Our Alban Gaultier, PhD, found last year that the drug can reduce the production of cytokines, which flood the body when the immune system spirals out of control.
A Source of Lifelong Behavior Issues
The discovery could have implications for autism and neurodegenerative diseases such as Alzheimer's.
VOTE! Brain Discovery Fighting It Out in STAT Bracket Contest
UPDATE: The University of Michigan came out on top with a potential treatment for tinnitus. Congrats to them and to the Kipnis team for a great performance!
An Explanation for Brain Cell Death in Alzheimer’s, Parkinson’s
Now we may know why specific brain cells die in Alzheimer’s, Parkinson’s and other neurodegenerative diseases.